Weight Loss Surgery

Approach Considerations

9 Foods to Help You Lose Weight
Beans Inexpensive, filling, and versatile, beans are a great source of protein. Tolerance for adverse effects is limited; most persons who are obese are fairly healthy in the short term, but the risk for adverse drug effects is enhanced because patients must take antiobesity medications for extended periods possibly for the rest of their lives. Self-monitoring of caloric intake and physical activity. CB1-receptor antagonists showed great potential for weight management in several human trials. A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. It sounds too good to be true.

Start Here

Obesity Treatment & Management

Olestra consists of a sucrose polyester backbone with fatty-acid side chains; this structure makes the molecule too large for digestive enzymes of the gut to hydrolyze. In many trials, olestra had fairly good tolerability, although foods containing it are apparently less tasty than foods cooked in regular fat.

The major adverse effects reported were flatulence, bloating, diarrhea, and loose stools. Because of concerns regarding the possible malabsorption of fat-soluble vitamins, the FDA requires all olestra-prepared foods to be supplemented with these vitamins. Benecol contains stanols, predominantly sitostanol and campestan; Take Control is made up of sterols, primarily beta-sitosterol and campesterol. Weight-loss benefits have not been demonstrated.

Surgical therapy for obesity bariatric surgery is the only available therapeutic modality associated with clinically significant and relatively sustained weight loss in subjects with morbid obesity associated with comorbidities. Evidence shows that well-performed bariatric surgery, in carefully selected patients and with a good multidisciplinary support team, substantially ameliorates the morbidities associated with severe obesity. Although bariatric surgery is the only therapeutic method associated with significant and rapid weight loss, it is expensive, highly procedure and surgeon specific, and certainly not the solution for the burgeoning obesity epidemic.

Patient selection for bariatric procedures must be addressed along the same stringent lines as those discussed earlier for the selection of patients for medical weight-management programs.

Comorbidities that have been reported to be improved, ameliorated, or resolved through bariatric surgery include the following:. Other reports suggest improved quality of life and fertility after bariatric surgery. Although other outcomes are difficult to demonstrate and are awaiting clear documentation, these procedures may substantially reduce macrovascular complications eg, myocardial infarction , stroke, amputations, obesity-related malignancies, and a predisposition to infection, hernias, and varicose veins.

Although most bariatric procedures were initially developed in the setting of laparotomies, they now are increasingly performed laparoscopically, with reduced postoperative morbidity.

The laparoscopic approach to bariatric surgery is particularly well developed in Europe. Available data on the effectiveness of many of these procedures are still relatively scant. However, reports and meta-analyses from large numbers of patients on the most commonly performed procedures gastric restriction and gastric bypass lend veracity to the long-term effectiveness of bariatric surgery.

Guidelines from the American Association of Clinical Endocrinologists, The Obesity Society, and the American Society for Metabolic and Bariatric Surgery endorse sleeve gastrectomy as an effective alternative to gastric banding, gastric bypass, and other types of bariatric surgery, saying that the procedure has advanced beyond the investigational stage.

However, the guidelines do not recommend any bariatric procedure as preferable over the others for patients with severe obesity. Flickinger and associates, in an examination of patients who received a Roux-en-Y gastric bypass, recorded a mean weight loss of 51 kg in 18 months, which was then maintained over 36 months of follow-up.

Roux-en-Y and other gastric-bypass procedures generally result in more weight loss than do gastric-restriction procedures. According to a study by Plecka et al, in patients who are morbidly obese, gastric bypass but not restrictive surgery apparently reduces the risk levels for the development of type 2 diabetes and myocardial infarction to those for the general population. However, the mortality risk in these patients nonetheless remains higher than that in the general population.

Improvement in glucose control was unrelated to baseline BMI or overall weight loss. A Norwegian study compared gastric bypass with duodenal switch and determined that duodenal switch surgery was associated with greater weight loss and greater reductions in total and LDL-C levels. However, duodenal switch surgery was also associated with reductions in concentrations of vitamin A and hydroxyvitamin D, as well as with increased adverse effects.

Similarly, a randomized trial from Sweden found greater postoperative weight loss in patients who had duodenal switch surgery than in those who had gastric bypass. Fasting glucose and HgA1c were also lower at 3 years in the duodenal switch group. A study by Schiavon et al indicated that bariatric surgery can lead to a reduction in the number of antihypertensive drugs required by persons with obesity taking multiple blood pressure agents and in some cases can eliminate the need for any such medications.

The investigators found that Emerging data suggest that gastric pacing achieved by using implantable electrodes may have significant weight-loss effects. This outcome was initially discovered with the use of gastric pacemaker devices for gastroparesis in patients with diabetes. Other adjunctive procedures that may be performed but that have an unclear utility include visceral fat removal, omentectomy, subcutaneous fat panniculectomy, and large-volume subcutaneous fat liposuction.

Klein and colleagues indicated that liposuction in itself has no utility in improving cardiac risk factors among patients with obesity. Some procedures, such as jaw wiring and insertion of a gastric balloon or a gastric wrap, are no longer popular because of their poor results compared with those of newer procedures and because of their high complication rates.

Vagotomy has also declined in popularity, as the weight lost is typically regained within a few years. The mortality rate associated with standard bariatric surgical procedures in an experienced center should not exceed 1. The surgical mortality rate is less than 0. In addition, gastric-specific operations can be associated with persistent vomiting and metabolic alkalosis.

These operations are also more commonly associated with weight-loss failure and inadvertent splenectomy than are other surgical methods. Malabsorptive procedures gastric bypass can lead to deficiency of thiamine, iron, vitamin D, and vitamin B Prevalences for adverse events with gastric resection procedures with or without bypass are approximately as follows [ ]:. Patients who receive bypass procedures are particularly prone to micronutrient deficiency states, especially of calcium, vitamin B, folate, and iron, as well as protein malnutrition.

Rare cases of postural hypotension and severe hypoglycemia from nesidioblastosis have been reported. Life-threatening hypoglycemia usually requires partial or total pancreatectomy, while severe postural hypotension that cannot be corrected with fludrocortisone and midodrine requires reversal of the surgery.

The following are among the major specific complications associated with malabsorptive operations:. Failure rates based on weight loss are controversial. The overall failure rates for malabsorptive procedures are relatively low, although the need for reversal of the surgery because of resulting adverse effects appears to be relatively high.

Despite the morbidity and mortality risk associated with bariatric surgery, the few reports involving follow-up on patients undergoing these procedures suggest overall improvement in quality of life. Even more convincing than this finding is that most subjects who undergo these procedures, despite their postoperative complications and difficulties, indicate that they would undergo the procedures again if necessary. Inpatient evaluations of obese patients are important in the immediate postoperative period after antiobesity surgery.

In addition, hospitalization may be required for the management of major complications, such as clinically significant respiratory or cardiac compromise. Weight-management programs may be based in an outpatient or inpatient setting. No rigorous evidence suggests that inpatient programs are necessarily superior to outpatient programs of similar structure and content, however. Inpatient programs may offer the convenience of easy access to patients and ease of monitoring, but they are not only expensive to run and difficult to reimburse, they also generally cause considerable disruption to the patients' regular routine.

In addition, they offer little guarantee of sustained effect. Because of the sheer prevalence of obesity and the anticipated worsening of the pandemic in the next few decades, prevention is by far the most desirable means to curb the medical and economic consequences of this condition. However, few trials have addressed this issue, and those performed thus far have had mixed results. Given the global proportions of obesity, a concerted approach is needed to address the problem and should involve the development of a massive public health education program aimed at adults and children as a means of changing their eating, activity, and behavioral habits.

Cooperative efforts will also be needed among public health authorities, caterers, the fast food industry, and organizers of sports and outdoor games.

Results of some public health education initiatives in Singapore and parts of China that are only now being evaluated suggest, as hoped, that such programs have the potential for reducing the incidence and prevalence of obesity and may also have an impact on the major comorbidities of obesity, such as type 2 diabetes and hypertension.

Until advances in gene therapy permit the alteration of genes that predispose to obesity, such programs are the only preventive options available. In select cases, consultation with a psychiatrist may be indicated. Psychiatric consultation should be sought for patients with psychiatric disorders and personality disorders eg, severe depression, mania, obsessive disorders that may be worsened by attempts at weight loss if not adequately treated and controlled.

As with the management of other chronic medical conditions eg, diabetes mellitus, hypertension, bronchial asthma , long-term success in the management of obesity is contingent on long-standing follow-up with the weight-loss program.

Experience obtained from the lifestyle intervention group of patients in the Diabetes Prevention Program and information drawn from the ongoing Diabetes Prevention Program Observation study have borne out the importance of regular follow-up. Patient visits may not need to occur as frequently during follow-up as during the initial weight-loss phase. Nevertheless, they are paramount if the lessons learned regarding diet, exercise habits, and behavioral patterns are to be maintained.

Obesity in the Early Childhood Years: State of the Science and Implementation of Promising Solutions: Prevalence of obesity and trends in the distribution of body mass index among US adults, Comorbidities of obesity in school children: Prevalence of self-reported clinically diagnosed sleep apnea according to obesity status in men and women: National Health and Nutrition Examination Survey, Body mass index, effect modifiers, and risk of pancreatic cancer: Adiposity and cancer at major anatomical sites: Association between obesity and health-related quality of life in patients with coronary artery disease.

Int J Obes Lond. Am J Clin Nutr. Lifestyle modification for obesity: Cawley J, Meyerhoefer C. The medical care costs of obesity: The costs of obesity in the workplace. J Occup Environ Med. Weight Loss Markets for Products and Services. A New Name for Obesity?. Healthy percentage body fat ranges: Segmental bioelectrical impedance analysis: Appropriate BMI for Asian populations. Definition of metabolic syndrome: Adolescent BMI trajectory and risk of diabetes versus coronary disease.

N Engl J Med. Association of changes in body mass index during earlier adulthood and later adulthood with circulating obesity biomarker concentrations in middle-aged men and women. Gastric bypass for treating severe obesity. Effects of increased intra-abdominal pressure in severe obesity.

Surg Clin North Am. Obesity and the risk of stillbirth: Am J Obstet Gynecol. Estimating the risk of type-2 diabetes using obese-years in a contemporary population of the Framingham Study.

Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans. Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. Kasiske BL, Napier J. Glomerular sclerosis in patients with massive obesity. Glomerulomegaly and focal segmental glomerulosclerosis associated with obesity and sleep-apnea syndrome. Am J Kidney Dis.

Sleep duration and five-year abdominal fat accumulation in a minority cohort: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Obesity due to melanocortin 4 receptor MC4R deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion.

J Clin Endocrinol Metab. The role of adipose tissue as an endocrine gland. Expert Rev Cardiovasc Ther. Acute, short-term hyperinsulinemia increases olfactory threshold in healthy subjects. Plasma leptin levels and incidence of heart failure, cardiovascular disease, and total mortality in elderly individuals. Behavioral and neuroendocrine characteristics of the night-eating syndrome.

Reduced appetite and body mass index with delayed puberty in a mother and son: Facts about Physical Activity. Centers for Disease Control and Prevention. Relative hypocortisolism is associated with obesity and the metabolic syndrome in recurrent affective disorders. The response to long-term overfeeding in identical twins. Preventing and treating childhood obesity: Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Frayling TM, Ong K.

Piecing together the FTO jigsaw. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. Developments in obesity genetics in the era of genome-wide association studies.

Leptin concentrations are a predictor of overweight reduction in a lifestyle intervention. Int J Pediatr Obes. Melanocortins and body weight: Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity.

Obesity as a neuroendocrine disease: Congenital leptin deficiency due to homozygosity for the DeltaG mutation: Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndrome. Perceived weight status, overweight diagnosis, and weight control among US adults: Prevalence of obesity and trends in body mass index among US children and adolescents, Am J Public Health.

Neighborhoods, obesity, and diabetes--a randomized social experiment. National, regional, and global trends in body-mass index since The "thrifty genotype" in BMI was right all along: Association of adolescent obesity with risk of severe obesity in adulthood. Annual deaths attributable to obesity in the United States. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Health hazards of obesity.

Endocrinol Metab Clin North Am. Excess deaths associated with underweight, overweight, and obesity. Association between body-mass index and risk of death in more than 1 million Asians. Body-mass index and mortality among 1. General and abdominal obesity and risk of death among black women.

Obesity as a Risk Factor for Prostatic Enlargement: A Retrospective Cohort Study in Korea. Normal body mass index rather than obesity predicts greater mortality in elderly people: J Am Geriatr Soc. BMI and all-cause mortality among Japanese older adults: Child and adolescent fast-food choice and the influence of calorie labeling: Interventions for preventing obesity in children.

Cochrane Database Syst Rev. J Am Coll Cardiol. New US obesity guidelines. Treat the weight first. Pharmacological management of obesity: Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: Lighten Up randomised controlled trial. Medications for weight reduction. Med Clin North Am.

Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diets with high or low protein content and glycemic index for weight-loss maintenance. Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Long-term persistence of hormonal adaptations to weight loss. Long-term effect of intensive lifestyle intervention on cardiovascular risk factors in patients with diabetes in real-world clinical practice: Proimos J, Sawyer S.

Obesity in childhood and adolescence. Body composition and childhood obesity. Older Adults and the Elderly. Rome, October Food and Agriculture Organization of the UN. Correction factors for the calculation of metabolic equivalents MET in overweight to extremely obese subjects.

Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: Very low calorie diets. Preoperative very low-calorie diet and operative outcome after laparoscopic gastric bypass: Water consumption increases weight loss during a hypocaloric diet intervention in middle-aged and older adults.

Influence of water drinking on resting energy expenditure in overweight children. Influences of normobaric hypoxia training on physical fitness and metabolic risk markers in overweight to obese subjects.

Effect of exercise on month weight loss maintenance in overweight women. Exercise-training enhances fat-free mass preservation during diet-induced weight loss: Weight loss, exercise, or both and physical function in obese older adults. Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: Maintaining a high physical activity level over 20 years and weight gain.

Translating weight loss and physical activity programs into the community to preserve mobility in older, obese adults in poor cardiovascular health.

Cognitive and behavioral approaches in the treatment of obesity. The 'Healthy Dads, Healthy Kids' randomized controlled trial: Changes in diet and lifestyle and long-term weight gain in women and men.

Insufficient sleep undermines dietary efforts to reduce adiposity. US Food and Drug Administration. United States Food and Drug Administration. Orlistat, a new lipase inhibitor for the management of obesity. FDA approves Belviq to treat some overweight or obese adults. Schedules of Controlled Substances: Multicenter, placebo-controlled trial of lorcaserin for weight management. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: FDA approves weight-management drug Saxenda.

Serretti A, Mandelli L. Antidepressants and body weight: Methylphenidate reduces energy intake and dietary fat intake in adults: Zonisamide for weight loss in obese adults: Octreotide therapy of pediatric hypothalamic obesity: Role of metformin for weight management in patients without type 2 diabetes.

Effects of glucagon-like peptide-1 receptor agonists on weight loss: Bupropion for weight reduction. Cannabinoid receptor antagonists and obesity. Curr Opin Investig Drugs. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes.

The role of pramlintide for weight loss. Inhibition of food intake in obese subjects by peptide YY PYY as an anti-obesity drug target. Peptide YY is a regulator of energy homeostasis in obese children before and after weight loss. Efficacy of metreleptin in obese patients with type 2 diabetes: Novel strategy for the use of leptin for obesity therapy.

Expert Opin Biol Ther. Bariatric surgery and long-term cardiovascular events. Perioperative safety in the longitudinal assessment of bariatric surgery. Vertical banded gastroplasty for the treatment of morbid obesity. The Greenville gastric bypass. Progress report at 3 years. Morbidity and mortality before and after bariatric surgery for morbid obesity compared with the general population.

Bariatric surgery versus conventional medical therapy for type 2 diabetes. Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: Hedberg J, Sundbom M. Superior weight loss and lower HbA1c 3 years after duodenal switch compared with Roux-en-Y gastric bypass--a randomized controlled trial.

Surg Obes Relat Dis. Gastric pacing as therapy for morbid obesity: Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. Postoperative metabolic and nutritional complications of bariatric surgery. Gastroenterol Clin North Am. Abbott Laboratories agrees to withdraw its obesity drug Meridia. Food and Drug Administration. Reductions in medications with substantial weight loss with behavioral intervention.

FDA approves weight-management drug Qsymia. A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adults. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. Diagnostic performance of BMI percentiles to identify adolescents with metabolic syndrome.

Gastric band is first step surgery for morbidly obese teens. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. Effects of bariatric surgery on mortality in Swedish obese subjects. Bariatric surgery, Bypass surgery, Gastric banding, Obesity surgery.

On this page Basics Summary Start Here. Resources Find an Expert. Who Is It For? Sleeve Gastrectomy BroadcastMed - St.

Gastric Bypass National Institutes of Health. A dissonance-based intervention for women post roux-en-Y gastric bypass surgery Weight Loss Surgery -- see more articles. An Option for Teens? American Academy of Pediatrics Also in Spanish. Pregnancy After Gastric Bypass:

Patient Screening, Assessment, and Expectations